PF-Atlas › Mechanisms › Prostacyclin Analog
Prostacyclin Analog in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Prostacyclin Analog is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 2 clinical trials acting through this mechanism.
Drugs targeting Prostacyclin Analog
Clinical trials
Medical disclaimer. This is a research summary, not medical advice.